Information for patients

Categories

You can filter the research news achive by selecting one or multiple categories from the following list.















  Show all news

 

5 September 2014

Effects of testosterone replacement therapy in men with hypogonadism

Alleged concerns regarding risk of cardiovascular disease with testosterone replacement therapy have been promulgated recently. However, a large and growing number of intervention studies (where medication was used) show to the contrary that testosterone therapy reduces cardiovascular risk factors (diseases of the heart and blood vessels) and confers multiple beneficial health effects. Thus, fears promoted by some recent flawed studies need to be critically re-evaluated.

This summary gives an overview of a comprehensive review of studies that have investigated health effects and safety of testosterone therapy. As outlined here, the position that hypogonadism (also known as testosterone deficiency) should be regarded as a risk factor for cardiovascular disease is supported by a rapidly expanding body of evidence.

Last updated: 2018
L.ZA.MKT.GM.10.2016.1381